Trades on 1 secondary market

Cofactor Genomics

Cofactor Genomics is a precision-medicine biotechnology company that applies RNA-sequencing and machine learning to build predictive immuno-oncology diagnostics. Its flagship OncoPrism assay is designed to predict which cancer patients will respond to immunotherapy, and the company runs the multi-ce

minimal 11.2 / 100 0 APIs View provider profile →

Company Genomics Precision Medicine Diagnostics Immuno-Oncology RNA Sequencing

Cofactor Genomics is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.

Where It Trades

N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.